Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC appointment

This article was originally published in The Tan Sheet

Executive Summary

Jon Leibowitz has been sworn in as one of five Federal Trade commissioners, replacing Mozelle Thompson, a commissioner since 1996. Leibowitz was Democratic chief counsel and staff director to the Senate Antitrust Subcommittee from 1997 to 2000, and chief counsel to Senator Herb Kohl (D-Wisc.) from 1989 to 2000. Most recently Leibowitz was vice president of congressional affairs for the Motion Picture Association of America. His appointment follows shortly after Deborah Majoras replaced Timothy Muris as chairman (1"The Tan Sheet" Aug. 16, 2004, In Brief)...

You may also be interested in...



FTC administrators

Deborah Majoras "is a highly talented and experienced lawyer, and will be an excellent chairman" of the Federal Trade Commission, Timothy Muris says of his successor in a recent statement. Muris' resignation as FTC chairman takes effect Aug. 15; Majoras' nomination was announced in May (1"The Tan Sheet" May 17, 2004, p. 14)...

Probiotics And Cold Remedies Boost Recordati In 2023

Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.

Falling Sales Force New Priorities At Roche

The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097244

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel